Showing results (41-50 of 3,356) with videos related to

Sort By:
Pageof 336
Experimental & Applied Acarology|June 1, 1995
Artificial immunization of rabbits with Hyalomma dromedarii tick-derived midgut antigenR Kumar, R Kumar
British Journal of Pharmacology|November 13, 2001
Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transportersC M Pariante, A Makoff, S Lovestone, et al.
FEBS Letters|January 6, 2000
The function of the microtubule-associated protein tau is variably modulated by graded changes in glycogen synthase kinase-3beta activityK Leroy, R Menu, J L Conreur, et al.
Biological Psychiatry|March 12, 1998
Apolipoprotein E: depressive illness, depressive symptoms, and Alzheimer's diseaseC Holmes, C Russ, G Kirov, et al.
Neuroscience|December 12, 2001
Tau proteins with frontotemporal dementia-17 mutations have both altered expression levels and phosphorylation profiles in differentiated neuroblastoma cellsT G Mack, R Dayanandan, M Van Slegtenhorst, et al.
Neurobiology of Aging|December 9, 2009
Dietary restriction delays aging, but not neuronal dysfunction, in Drosophila models of Alzheimer's diseaseF Kerr, H Augustin, M D W Piper, et al.
Neuroscience Letters|December 11, 2003
Mutant presenilin 1 proteins induce cell death and reduce tau-dependent processes outgrowthK Leroy, A Boutajangout, J Richardson, et al.
Neuroreport|July 28, 1997
Arylsulphatase A pseudodeficiency in vascular dementia and Alzheimer's diseaseM Philpot, K Lewis, M L Pereria, et al.
Biological Psychiatry|July 1, 1999
Lithium reduces tau phosphorylation: effects in living cells and in neurons at therapeutic concentrationsS Lovestone, D R Davis, M T Webster, et al.
Neuroscience Letters|April 6, 2001
Glycogen synthase kinase-3beta immunoreactivity is reduced in the prefrontal cortex in schizophreniaC Beasley, D Cotter, N Khan, et al.
Pageof 336